MTOR and hepatocellular carcinoma: The exosomes of mesenchymal stem cells derived from adipose tissue effectively mediated the delivery of miR-199a to HCC cells, while AMSC-Exo-199a targeted mTOR and subsequently inhibited the mTOR pathway, making HCC cells sensitive to adriamycin.